Crossref
Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia
Journal of Chinese Pharmaceutical Sciences · 30.05.2026 · 35 (5) · 491
DOI: 10.5246/jcps.2026.05.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.05.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia. Journal of Chinese Pharmaceutical Sciences, 35(5), 491. https://doi.org/10.5246/jcps.2026.05.035
Vancouver
Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia. Journal of Chinese Pharmaceutical Sciences. 2026;35(5):491. doi:10.5246/jcps.2026.05.035
BibTeX
@article{euvimed2026,
title = {Development and validation of a risk prediction model for tigecycline-induced thrombocytopenia},
journal = {Journal of Chinese Pharmaceutical Sciences},
year = {2026},
volume = {35},
number = {5},
pages = {491},
doi = {10.5246/jcps.2026.05.035}
}
EUVIMED